Results show that this aromatic aldehyde markedly inhibits all three, as well as also affects HbS polymerisation and sickling, but also stimulates an unidentified K+ efflux pathway. These additional actions of o-vanillin may be of significant consideration when designing similar compounds to ameliorate the complications of SCD.